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http://www.biomedcentral.com/1756-0500/7/648RESEARCH ARTICLE Open Access1-day bowel preparation with polyethylene glycol
3350 is as effective and safe as a 3-day preparation
for colonoscopy in children
Serge A Sorser1*, Venkata Konanki2, Alice Hursh3, Karen Hagglund4 and Hernando Lyons5Abstract
Background: Polyethylene Glycol 3350 (Miralax®) without electrolytes is commonly used for 3–4 days as bowel
preparation for colonoscopy in children. One-day preparation has been anecdotally reported to be effective but
there are few published prospective studies comparing the safety and efficacy of one-day preparation with that of
three-day preparation. This study was conducted to compare the efficacy and safety of a one-day bowel
preparation with Miralax® with that of a three-day preparation for colonoscopy in children.
Methods: We conducted a prospective, randomized controlled trial with children age 2–21 yrs. undergoing elective
colonoscopy. Patients were randomly assigned to receive Miralax® for either one or three days. Children with
known electrolyte disturbances, dehydration, fecal impaction, metabolic or renal disease were excluded. A
metabolic panel was monitored before and after bowel preparation. Subjects reported the tolerability and side
effects of Miralax® via a survey. Effectiveness of the bowel preparation was assessed using a stool diary and a bowel
cleansing scale during colonoscopy.
Results: 32 subjects were enrolled; 18 received one-day bowel preparation and 14 received 3-day preparation.
There were no differences between the groups in efficacy of bowel preparation based on colonoscopic grading or
the safety of the preparation. One-day preparation was as well tolerated as three-day preparation.
Conclusion: Miralax® used one day as bowel preparation for elective colonoscopy in children is safe, effective and
well tolerated. Physicians should consider offering a one-day option for bowel preparation, which would allow
children to miss fewer days of school prior to colonoscopy.
Trial registration: Trial Registration Number: NCT02174497. Date of Registration: 02 May, 2014 URL of register:
clinicaltrials.gov.
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Colonoscopy in children and young adults is performed
by gastroenterologists for a variety of indications, includ-
ing but not limited to evaluation of rectal bleeding,
chronic diarrhea, family history of polyposis syndromes
and surveillance for colon cancer in patients with inflam-
matory bowel disease [1-4]. A successful bowel prepar-
ation that enables clear visualization of the intestinal
mucosa is essential to diagnose and treat the underlying* Correspondence: ssorser@gmail.com
1Department of Gastroenterology, Providence Hospital and Medical Center,
Southfield, MI, USA
Full list of author information is available at the end of the article
© 2014 Sorser et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.pathology. Currently, gastroenterologists use a variety of
colon cleansing preparations, but Polyethylene Glycol
(PEG) 3350 given for three to four days appears to be
standard [5-8]. Though it is well tolerated, safe and effect-
ive [5,9-11], the duration of preparation may cause disrup-
tion to the routine and missed school days. To date, there
is limited data that shows efficacy of a shorter duration of
bowel preparation with PEG [12-14]. This study aims to
compare the efficacy and safety of a one-day preparation
with that of a three-day preparation with PEG 3350 as
preparation for colonoscopy in children and young adults.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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A prospective, randomized controlled study was con-
ducted at St. John Hospital and Medical Center in Detroit,
MI between February 2008 and February 2010, after
obtaining Institutional Review Board (IRB) approval from
the St. John Hospital IRB, which provides oversight for
both the scientific and ethical aspects of research studies
conducted at our facility. Children between 2 and 21 years
of age undergoing elective colonoscopy were enrolled into
the study. The exclusion criteria for this study were a his-
tory of allergy to PEG, fecal impaction, known electrolyte
abnormalities, as well as renal and metabolic diseases.
Written consent from subjects or their parents was ob-
tained at the time of enrollment.
Subjects were randomly assigned to either a one-day
or a three-day preparation group. Those in the one-day
group were instructed to take 4.5gm/kg/day PEG 3350
up to a maximum dose of 255 g and those in the three-
day group to receive 1.5 g/kg/day, up to a daily max-
imum dose of 85gm and total dose of 255 g. Written in-
structions were provided to take PEG with any clear
liquid. Subjects were asked to take 1 scoop (17 g) of
PEG mixed with 8 oz. of clear liquid every 30 minutes.
Those under 7 years of age were asked to take ½ scoop
(8.5 g) mixed with 4 oz. of clear liquid every 30 minutes.
Subjects in the three-day group were instructed to take a
regular diet for the first two days of preparation and a
clear liquid diet on the 3rd day. Subjects in the one-day
group were instructed to take clear liquid diet on the
day of bowel preparation. Subjects in both groups were
asked not to take anything by mouth (NPO) eight hours
before procedure except sips of water up to three hours
before procedure.
Demographic data such as age, gender, race, ethnicity
and weight were collected. Indications for colonoscopy
were recorded. Subjects were given written instructions re-
garding the total amount of PEG to be taken over one-day
or three-days, what to take it with, in terms of quantity and
frequency, and diet while undergoing bowel preparation.
Subjects were asked to report how tolerable (easy, tol-
erable or difficult) the preparation was and whether they
completely took PEG as prescribed. If the patient did
not take the entire prescribed regimen, reasons for not
completing the preparation were elucidated. Subjects
were also asked if they were willing to take the prepar-
ation again in the future, if they had to. Serum electrolytes,
blood urea nitrogen (BUN), creatinine and serum osmolal-
ity were checked before and after the bowel preparation to
monitor the safety of the preparation. While undergoing
the preparation, a stool diary consisting of stool frequency,
color and consistency was completed by all subjects.
At the time of colonoscopy, the pediatric gastroenterolo-
gist (HL) involved in the study, who was blinded to the
preparation given, graded the degree of bowel cleansing aspoor, fair, good or excellent depending on the type and
amount of liquid debris or stool present. Endoscopic im-
ages were also evaluated by a blind reviewer (a second
pediatric gastroenterologist, MEB). All segments of the
colon were evaluated (cecum, ascending colon, transverse
colon, descending colon, sigmoid colon, rectum), with
photographs of each segment reviewed independently by
the primary endoscopist and the blinded reviewer. A pre-
viously described grading system was used for this study
[5]. A grading of excellent required no stool or small
amount of thin fecal fluid to be seen. A good grading was
characterized by liquid fecal matter that could be removed
by suction easily. A grading of fair meant that thick stool
was present, requiring suction with water lavage. A grading
of poor required solid stools present with poor visualization
of the mucosa. A grading of good or excellent was accept-
able for the evaluation of the colonic mucosa and a repeat
colonoscopy was not required. Primary outcomes measured
were efficacy, safety and tolerability of PEG given one-day
vs. three days for bowel preparation for colonoscopy.
Frequency and descriptive statistics were calculated. As-
sociations between categorical variables and treatment
group were measured by Chi-square or Fisher’s exact tests.
Differences between groups on continuous variables were
assessed using Student’s t-tests. P values < 0.05 were con-
sidered to indicate statistical significance. SPSS version
12.0 was used for statistical analysis.
Funding for this study was provided by the St. John
Hospital & Medical Center Graduate Medical Education
Research Committee.
Results
A total of 32 subjects, 18 in the one-day group and 14 in
three-day group, were recruited and included in the data
analysis. No patients were excluded from this study based
on the exclusion criteria listed. The mean age of subjects
was 13.6 and 11.6 years in the one and three day groups,
respectively. In the one-day prep group, 8/18 subjects
were male, whereas, 10/14 subjects were males in the
three-day group. The majority of patients in both groups,
15/18 in the one-day group and 12/14 in the three-day
group, were Caucasian. In both groups, the most common
indication for colonoscopy was rectal bleeding (11/18 in
the one-day group versus 10/14 in the three-day group).
Other indications were chronic diarrhea, abdominal pain,
family history of familial polyposis syndrome and Crohn’s
disease. This data is summarized in Table 1.
The vast majority of patients, 16 in the one-day group
and all 14 in the three-day group, indicated that the
bowel preparation was either acceptable or tolerable, but
this was not statistically significant. Most patients, 13/18
in the one-day group and 13/14 in the three-day group,
took the full prescribed amount of PEG. The remaining
patients, 5/18 in the one-day group and 1/14 in the
Table 1 Demographics and indications for colonoscopy
Demographics 1-Day prep 3-Day prep P





Age 13.6 + 4.6 11.6 + 4.9 0.237
Gender 0.165
Male 8 (44) 10 (71)
Female 10 (56) 4 (29)
Race 1
Caucasian 15 (83) 12 (86)
African-American 3 (17) 2 (14)
Indication for colonoscopy
Rectal bleeding 11 (61) 10 (71) 1
Chronic diarrhea 6 (33) 4 (29) 0.712
Abdominal pain 4 (22) 8 (57) 0.068
Crohn’s disease 2 (11) 0 (0) 0.492
Table 3 Efficacy of PEG
1-Day preps 3-Day prep P
n = 18 n = 14
n (%) n (%)
Effectiveness of bowel prep 1
Excellent 16 (89) 12 (85)
Good 2 (11) 2 (15)
Colonoscopic evaluation of prep 0.437
Excellent or good 18 (100) 13 (93)
Fair 0 (0) 1 (7)
Repeat colonoscopy needed 0 (0) 1 (7) 0.452
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they indicated that their stools were clear and did not
take the remaining PEG. Almost all of the patients, 16/
18 in the one-day and 14/14 in the three-day group indi-
cated that they were willing to take their respective
preparations again, if needed. Again, these were not sta-
tistically significant (p = 0.492). Tolerability data is listed
in Table 2.
Based on a stool diary completed by the subjects or
their parents, the bowel preparation was assessed to be
excellent in 16/18 in the one-day group and in 12/14 in
the three-day group. Based on the endoscopic evaluation
of bowel cleansing, a grading of excellent or good was
given to 18/18 (14/18 excellent and 4/18 good) in the
one-day group and 13/14 (9/14 excellent and 4/14 good)
in the three-day group. The remaining patient in the
three-day group received a grading of fair and thatTable 2 Tolerability of PEG
1-Day prep 3-Day prep P
n = 18 n = 14
n (%) n (%)
Ease of administration 0.492
Easy or tolerable 16 (89) 14 (100)
Difficult 2 (11) 0 (0)
Compliance 0.196
Full 13 (72) 13 (93)
Partial 5 (28) 1 (7)
Willingness to take again 0.492
Yes 16 (89) 14 (100)
No 2 (11) 0 (0)patient required a repeat endoscopic examination. The
blinded reviewer gave a grading of good or excellent for
all patients in both groups (9/18 excellent and 9/18 good
for the one-day group and 7/14 excellent and 7/14 good
for the three-day group). Agreement was reached in 22/
32 patients (68.8%) The overall kappa correlation for the
32 cases between the two reviewers was 0.375, with a
kappa of 0.571 for the three-day group and 0.222 for the
one-day group. Please refer to Table 3 for data on effi-
cacy of PEG in the one and three day groups.
The major side effects reported by patients were nausea,
vomiting and abdominal pain. In the one-day group, 8/18
complained of nausea, 1/18 noted vomiting and 4/18
described abdominal pain, whereas 3/14 complained of
nausea, 2/14 of vomiting and 3/14 of abdominal pain in
three-day group. These symptoms were mild to moderate
in both groups. The incidence of these side effects was not
statistically significantly different between the two groups.
All adverse events are summarized in Table 4.
Review of serologic evaluation showed 2/18 in the one-
day group and 2/14 in the three-day group had slightly
low osmolality (277 milliosmoles/kg and 278 millosmoles/
kg in the one-day group and 274 milliosmoles/kg and 275Table 4 Safety of PEG
1-Day prep 3-Day prep P
n = 18 n = 14
n (%) n (%)
Side effects
Nausea 8 (44) 3 (22) 0.266
Vomiting 1 (6) 2 (14) 0.568
Abdominal pain 4 (22) 3 (21) 1
Labs before the prep 1
Normal 16 (89) 12 (86)
Abnormal 2 (11) 2 (14)
Labs after the prep 1
Normal 13 (77) 10 (71)
Abnormal 5 (23) 4 (29)
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aration labs performed as part of the study. These were not
associated with any clinical symptoms. Similarly, 5/18 in
the one-day and 4/14 in the three-day group had abnormal
serology following the preparation. In the one-day group,
one patient had an elevated osmolality of 315, two patients
had a low osmolality of 275 & 277 and two patients
had low serum bicarbonate of 19 & 20. In the three-day
group, two patients had low osmolality of 275 & 277 and
two had low bicarbonate of 15 & 17. These serologic de-
rangements were not associated with any clinical symptoms
and the incidence of these abnormalities was not statisti-
cally significantly different between the two groups.
Discussion
The importance of a safe, easily tolerable and effective col-
onoscopy preparation, particularly in the pediatric popula-
tion, is paramount for both diagnostic and, at times,
therapeutic reasons. This is important for the patient in
terms of acceptability and missed days of school and his/
her parents, in terms of taking time off of work. This is
one of the first prospective studies evaluating the use of
PEG 3350 without electrolytes for a one-day bowel prepar-
ation for colonoscopy in children and young adults in
comparison with the three-day preparation. The data from
our study indicates that the safety, efficacy and tolerability
of bowel preparation with PEG given one-day are not in-
ferior to that of three-day preparation.
At our institution, PEG is usually used as a three day
bowel preparation in children. A recent retrospective study
by Adamiak et al. reported an efficacy of 93% with one-day
use of PEG for bowel preparation in children [12]. In our
patient population, a similar efficacy (100%) with one-day
preparation was noted.
The side effects reported in both groups in this study
have previously been reported with use of PEG for bowel
preparation as well as for other indications such as con-
stipation, fecal impaction and bowel irrigation. Although
there was a slightly higher incidence of side effects in
the one-day group compared to three-day group, they
were well tolerated and were not statistically significant.
Following completion of the bowel preparation, low
serum bicarbonate and low osmolality were noted in two
patients in both groups, but they were of no clinical sig-
nificance in this study. As the patients were asymptom-
atic, repeat serologic evaluation was not undertaken at a
later time to document normalization.
In the one-day group, 89% of patients reported that the
preparation was easy or tolerable and 72% completely took
the prescribed amount of PEG based on their weight.
Those that ingested only part of the preparation reported
that their stools were clear and they did not feel that it
was necessary to take the remaining PEG. This did not
affect the quality of bowel cleansing.The small sample size is an important limitation of our
study. This was due to a slow recruitment rate at our insti-
tution. Another possible limitation of this study is evalu-
ation bias by the gastroenterologist evaluating the degree
of bowel cleaning at colonoscopy. However, this has been
eliminated by having an independent gastroenterologist
(blind reviewer), not involved in the study, review the
endoscopic images and grade the preparation.
Conclusion
The data from our study suggests that bowel preparation
with PEG given as a one-day preparation is tolerable, safe
and effective, and is not inferior to a three-day prepar-
ation. A shorter duration of bowel preparation will increase
compliance, reduce the number of school days missed for
children and workdays missed for their parents. However,
future studies with a larger sample size are necessary to
confirm these results. Furthermore, consideration for split
dose preparation, as is becoming the standard in the adult
population undergoing colonoscopy, may be considered
[15-17] as a part of future studies.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
VK and AH collected the data. KH conducted the statistical analysis. HL was one of
the reviewers of the bowel preparation, completed the IRB and conducted all of
the endoscopic evaluations. SS assisted in statistical analysis and completed the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
The authors of this manuscript would like to thank Dr. Mohammad El-Baba
for acting as the second blinded reviewer.
The manuscript has not been published elsewhere and is not in
consideration for publication in any other journal at this time. The study was
presented in abstract form at the North American Society for Pediatric
Gastroenterology, Hepatology and Nutrition (NASPGHAN). There are no
financial disclosures for any of the authors.
Author details
1Department of Gastroenterology, Providence Hospital and Medical Center,
Southfield, MI, USA. 2Department of Pediatrics, Chambersburg Hospital,
Chambersburg, PA, USA. 3Department of Pediatric Gastroenterology, British
Columbia Children's Hospital, Vancouver, British Columbia, Canada.
4Department of Medical Education, St. John Hospital and Medical Center,
Detroit, MI, USA. 5Department of Pediatric Gastroenterology, St. John Hospital
and Medical Center, Wayne State University School of Medicine, Detroit, MI,
USA.
Received: 7 August 2014 Accepted: 28 August 2014
Published: 15 September 2014
References
1. Hassall E, Barclay GN, Ament ME: Colonoscopy in childhood. Pediatrics
1984, 73(5):594–9.
2. Sasaki H, Yagucji T, Hasegawa K, Lee B, Noguchi T, Nagasako K: Pediatric
colonoscopy. Dis Colon Rectum 1981, 24(4):257–8.
3. Fox VL: Pediatric endoscopy. Gastrointest Endosc Clin N Am 2000,
10(1):175–94.
4. Wyllie R, Kay MH: Colonoscopy and therapeutic intervention in infants
and children. Gastrointest Endosc Clin N Am 1994, 4(1):143–60.
5. Panshankar DS, Uc A, Bishop WP: Polyethylene glycol 3350 without
electrolytes: a new, safe, effective, and palatable bowel preparation for
colonoscopy in children. J Pediatr 2004, 144(3):358–62.
Sorser et al. BMC Research Notes 2014, 7:648 Page 5 of 5
http://www.biomedcentral.com/1756-0500/7/6486. Hunter A, Mamula P: Bowel preparation for pediatric colonoscopy
procedures. J Pediatr Gastroenterol Nutr 2010, 51(3):246–61.
7. Barkun A, Chiba N, Enns R, Marcon M, Natsheh S, Pham C, Sadowski D,
Vanner S: Commonly used preparations for colonoscopy: efficacy,
tolerability, and safety–a Canadian association of gastroenterology
position paper. Can J Gastroenterol 2006, 20(11):699–710.
8. Phatak UP, Johnson S, Husain SZ, Pashankar DS: Two-day bowel
preparation with polyethylene glycol 3350 and bisacodyl: a new, safe,
and effective regimen for colonoscopy in children. J Pediatr Gastroenterol
Nutr 2011, 53(1):71–4.
9. Dahshan A, Lin C, Peters J, Thomas R, Tolia V: A randomized, prospective
study to evaluate the efficacy and acceptance of three bowel
preparations for colonoscopy in children. Am J Gastroenterol 1999,
94:3497–501.
10. Gremse D, Sacks A, Raines S: Comparison of oral sodium phosphate to
polyethylene glycol-based solution for bowel preparation for colonoscopy
in children. J Pediatr Gastroenterol Nutr 1996, 23:586–90.
11. Barrish J, Gilger M: Colon cleanout preparations in children and
adolescents. Gastroenterol Nurs 1993, 16:106–9.
12. Adamiak T, Altaf M, Jensen MK, Sultan M, Ramprasad J, Ciecierega T, Sherry K,
Miranda A, Sultan M, Ramprasad J, Ciecierega T, Sherry K, Miranda A: One-day
bowel preparation with polyethylene glycol 3350: an effective regimen for
colonoscopy in children. Gastrointest Endosc 2010, 71(3):573–7.
13. Walia R, Steffen R, Feinberg L, Worley S, Mahajan L: The tolerability, safety
and efficacy of PEG 3350 as a One Day bowel preparation in children.
J Pediatr Gastroenterol Nutr 2012, [Epub ahead of print].
14. Abbas MI, Nylund CM, Bruch CJ, Nazareno LG, Rogers PL: Prospective
evaluation of One-Day polyethylene glycol-3350 bowel preparation
regimen in children. J Pediatr Gastroenterol Nutr 2012, [Epub ahead of print].
15. Enestvedt BK, Tofani C, Laine LA, Tierney A, Fennerty MB: 4-liter split-dose
polyethylene glycol is superior to other bowel preparations, based on
systematic review and meta-analysis. Clin Gastroenterol Hepatol 2012,
10(11):1225–31.
16. Gurudu SR, Ramirez FC, Harrison ME, Leighton JA, Crowell MD: Increased
adenoma detection rate with system-wide implementation of a split-dose
preparation for colonoscopy. Gastrointest Endosc 2012, 76(3):603–8.
17. Seo EH, Kim TO, Kim TG, Joo HR, Park MJ, Park J, Park SH, Yang SY, Moon YS:
Efficacy and tolerability of split-dose PEG compared with split-dose
aqueous sodium phosphate for outpatient colonoscopy: a randomized,
controlled trial. Dig Dis Sci 2011, 56(10):2963–71.
doi:10.1186/1756-0500-7-648
Cite this article as: Sorser et al.: 1-day bowel preparation with
polyethylene glycol 3350 is as effective and safe as a 3-day preparation for
colonoscopy in children. BMC Research Notes 2014 7:648.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
